Anthony sinskey biography

  • Anthony J. Sinskey.
  • Anthony J. Sinskey, Sc. D., is a Professor of Microbiology at the Massachusetts Institute of Technology and holds positions as Co-Director of the Malaysia-MIT.
  • Dr.

    • •

    Dr. Anthony J. Sinskey

    University of Illinois at Urbana-Champaign, BS, 1962

    Massachusetts Institute of Technology, ScD, 1966

    Anthony J. Sinskey, Sc.D., is a Professor of Microbiology at the Massachusetts Institute of Technology and holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership Program and as Faculty Director of the MIT Center for Biomedical Innovation (CBI). He conducts interdisciplinary research in metabolic engineering focusing on the fundamental physiology, biochemistry and molecular genetics of important organisms. Dr. Sinskey is well known in the biopharmaceutical industry and has been a Scientific Co-founder of several biotechnology companies, including Genzyme Corporation, Natural Pharmaceuticals, Metabolix, Merrimack Pharmaceuticals, and Tepha. Dr. Sinskey has given more than 300 presentations at U.S. and International scientific meetings and congresses. He has received 31 issued patents, has made more than 30 invention disclosures and has

    •

    Anthony J. Sinskey

    Education

    • ScD, 1966, Massachusetts Institute of Technology
    • BS, 1962, Food Science, University of Illinois, Urbana-Champaign

    Research Summary

    The Sinskey Lab leverages an interdisciplinary approach to metabolic engineering — focusing on the fundamental physiology, biochemistry, and molecular genetics of important organisms to determine key factors that regulate the synthesis of different biomolecules. The lab supports a broad range of interests, examining amino acid metabolism in Corynebacterium glutamicum, bioremediation and bioconversion processes in Rhodococcus, and biopolymer synthesis in Gram-negative bacteria. As for eukaryotic systems, we study both lipid biosynthesis and embryogensis in oil palm, as well as the accumulation of secondary metabolites in tropical plants.

    Recent Publications

    1. Metabolic engineering of Corynebacterium glutamicum: Unlocking its potential as a key cell factory platform for organic acid production. Li, MH, Li, H, Zhan
    2. anthony sinskey biography

      3. •

      $203 Thousand

      Estimate Recalculated Sep 8, 2024 07:25PM EST

      Who is Anthony J Sinskey?

      Anthony J Sinskey does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include YIELD10 BIOSCIENCE, INC., MERRIMACK PHARMACEUTICALS INC, and APEX BIOVENTURES ACQUISITION CORP.

      SEC CIK

      Anthony J Sinskey's CIK is 0001368753

      Past Insider Trading and Trends

      2021 was Anthony J Sinskey's most active year for acquiring shares with 10 total transactions. Anthony J Sinskey's most active month to acquire stocks was the month of November. 2012 was Anthony J Sinskey's most active year for disposing of shares, totalling 3 transactions. Anthony J Sinskey's most active month to avlägsna stocks was the month of March. 2012 saw Anthony J Sinskey paying a total of $117,717.56 for 111,551 shares, this is the most they've acquired in one year. In 2014 Anthony J Sinskey cashed out on 65,000